>AT2G38400.1 |  AGT3 (ALANINEGLYOXYLATE AMINOTRANSFERASE 3) alanine-glyoxylate transaminase/ catalytic/ pyridoxal phosphate binding / transaminase 
MQRFAAKRSVQNISVSLWRRCISSTSQAATASVKDSDEFQARLPPFAYTPPPYTGPSADV 
ILSKRKEFLSPSMFCLYRKPLNIVDGKMQYLFDESGRRYLDAFAGIAVVNCGHCHPDVVE 
PVINQIKRLQHPTVLYLNHAIADFSEALASKLPGDLKVVFFTNSGTEANELALMMAKLYT 
GCQDIVAVRNGYHGNAAATMGATGQSMWKFNVVQNSVHHALNPDPYRGVFGSDGEKYAKD 
LQDLIQYGTTGHIAGFICEAIQGVGGIVELAPGYLSAAYDTVKKAGGLFIADEVQSGFAR 
TGNFWGFEAHNVVPDIVTMAKGIGNGFPLGAVVTTPEIAGVLTRRSYFNTFGGNSVSTTA 
GLAVLNVIEKEKLQENAAMVGSYLKEKLTQLKEKHEIIGDVRGRGLMLGVELVSDRKLKT 
PATAETLHIMDQMKELGVLIGKGGYFGNVFRITPPLCFTKDDADFLVEAMDYSMSKM*
>AT4G39660.1 |  AGT2 (ALANINEGLYOXYLATE AMINOTRANSFERASE 2) alanine-glyoxylate transaminase/ catalytic/ pyridoxal phosphate binding / transaminase 
MALQRQLLKRATSDIYHRRAISLLRTDFSTSPSIADAPPHIPPFVHQPRPYKGPSADEVL 
QKRKKFLGPSLFHYYQKPLNIVEGKMQYLYDESGRRYLDAFAGIVTVSCGHCHPDILNAI 
TEQSKLLQHATTIYLHHAIGDFAEALAAKMPGNLKVVYFVNSGSEANELAMMMARLYTGS 
LEMISLRNAYHGGSSNTIGLTALNTWKYPLPQGEIHHVVNPDPYRGVFGSDGSLYAKDVH 
DHIEYGTSGKVAGFIAETIQGVGGAVELAPGYLKSVYEIVRNAGGVCIADEVQTGFGRTG 
SHYWGFQTQDVVPDIVTMAKGIGNGLPLGAVVTTPEIASVLASKILFNTFGGNPVCSAGG 
LAVLNVIDKEKRQEHCAEVGSHLIQRLKDVQKRHDIIGDVRGRGLMVGIELVSDRKDKTP 
AKAETSVLFEQLRELGILVGKGGLHGNVFRIKPPMCFTKDDADFLVDALDYSISRL*
>AT3G22200.1 |  POP2 (POLLEN-PISTIL INCOMPATIBILITY 2) 4-aminobutyrate transaminase/ 4-aminobutyratepyruvate transaminase 
MVVINSLRRLARTTQVHLHSKYATCMSGNSTSRRIFTTEAAPEKKNTVGSKGHDMLAPFT 
AGWQSADLDPLVIAKSEGSYVYDDTGKKYLDSLAGLWCTALGGNEPRLVSAAVEQLNTLP 
FYHSFWNRTTKPSLDLAKVLLEMFTANKMAKAFFTSGGSDANDTQVKLVWYYNNALGRPE 
KKKFIARKKSYHGSTLISASLSGLPPLHQNFDLPAPFVLHTDCPHYWRFHLPGETEEEFS 
TRLAKNLEDLIIKEGPETIGAFIAEPVMGAGGVIPPPATYFEKVQAVVKKYDILFIADEV 
ICAFGRLGTMFGCDKYNIKPDLVTLAKALSSAYMPIGAILMSQEVADVINSHSSKLGVFS 
HGFTYSGHPVSCAVAIEALKIYKERNIPEYVAKVAPRFQDGVKAFASGSPIIGETRGTGL 
ILGTEFVDNKSPNEPFPPEWGVGAFFGAECQKHGMLVRVAGDGILMSPPLIISPEEIDEL 
ISIYGKALKATEEKVKELKAQHKK*
>AT1G80600.1 |  WIN1 (HOPW1-1-INTERACTING 1) N2-acetyl-L-ornithine2-oxoglutarate 5-aminotransferase/ catalytic/ pyridoxal phosphate binding / transaminase 
MASLSQITLPRAPSSEIGLLRRRLERPIIRTRIGFNGRIASVLTNAGDQAVSVKASVSQK 
VIEEEAKVIVGTYARAPVVLSSGKGCKLFDPEGKEYLDCASGIAVNALGHGDPDWLRAVT 
EQAGVLAHVSNVYYTIPQIELAKRLVASSFADRVFFCNSGTEANEAAIKFSRKFQRFTHP 
EDKEVATGFIAFTNSFHGRTLGALALTSKEQYRTPFEPIMPGVTFLEYGNIQAATDLIRS 
GKIAAVFVEPIQGEGGIYSATKEFLQSLRSACDAAGSLLVFDEVQCGLGRTGLMWAYEAF 
GVTPDIMTVAKPLAGGLPIGAVLVTEKVAETINYGDHGSTFAGSPLVCSAAIAVMDKVSK 
PSFLSSVSNKGRYFRDLLVKKLGGNSHVKEVRGEGLIIGVELDVPASSLVDACRDSGLLI 
LTAGKGNVVRIVPPLVISEEEIERAVEIMSQNLTALD*
>AT3G08860.1 |  alanine--glyoxylate aminotransferase putative / beta-alanine-pyruvate aminotransferase putative / AGT putative 
MRKLTAVNSLLKRNNYLLPRHGSSQTAAQRTSSVRETETETKLPKMPPFNYSPPPYDGPS 
TAEIIAKRREFLSPALFHFYNTPLNIVEAKMQYVFDENGRRYLDAFGGIATVSCGHCHPE 
VVNSVVKQLKLINHSTILYLNHTISDFAEALVSTLPGDLKVVFFTNSGTEANELAMMMAR 
LYTGCNDIVSLRNSYHGNAAATMGATAQSNWKFNVVQSGVHHAINPDPYRGIFGSDGEKY 
ASDVHDLIQFGTSGQVAGFIGESIQGVGGIVELAPGYLPAAYDIVRKAGGVCIADEVQSG 
FARTGTHFWGFQSHGVIPDIVTMAKGIGNGIPLGAVVTTPEIAGVLSRRSYFNTFGGNPM 
CTAAGHAVLRVLHEEKLQENANLVGSHLKRRLTLLKNKYELIGDVRGRGLMLGVEFVKDR 
DLKTPAKAETLHLMDQMKEMGVLVGKGGFYGNVFRITPPLCFTLSDADFLVDVMDHAMSK 
M*
>AT1G33590.1 |  disease resistance protein-related / LRR protein-related 
MNSSFTLFIFTFVIFLQCLNPTGAATCHPDDEAGLLAFKAGITRDPSGILSSWKKGTACC 
SWNGVTCLTTDRVSALSVAGQADVAGSFLSGTLSPSLAKLKHLDGIYFTDLKNITGSFPQ 
FLFQLPNLKYVYIENNRLSGTLPANIGALSQLEAFSLEGNRFTGPIPSSISNLTLLTQLK 
LGNNLLTGTIPLGVANLKLMSYLNLGGNRLTGTIPDIFKSMPELRSLTLSRNGFSGNLPP 
SIASLAPILRFLELGHNKLSGTIPNFLSNFKALDTLDLSKNRFSGVIPKSFANLTKIFNL 
DLSHNLLTDPFPVLNVKGIESLDLSYNQFHLNTIPKWVTSSPIIFSLKLAKCGIKMSLDD 
WKPAQTFYYDFIDLSENEITGSPARFLNQTEYLVEFKAAGNKLRFDMGKLTFAKTLTTLD 
ISRNLVFGKVPAMVAGLKTLNVSHNHLCGKLPVTKFPASAFVGNDCLCGSPLSPCKA*
>AT5G46180.1 |  delta-OAT ornithine-oxo-acid transaminase 
MAATTRRLLYYVSKRFSTAGVRRSYGGLPQSNSKSPPSSSQRLMELESEFSAHNYHPVPV 
VFSRANGSTIWDPEGKRYIDFLAAYSAVNQGHCHPKIMKALQEQVEKLTLSSRAFYNDKF 
PVFAERLTNMFGYDMVLPMNTGAEGVETALKLARKWGHEKKNIPKDEAIIVSCCGCFHGR 
TLAIVSMSCDNDATRGFGPLLPGNLKVDFGDADSLEKIFKEKGDRIAGFLFEPIQGEAGV 
IIPPDGYLKAVRELCTKYNVLMIADEVQSGLARSGKMLACDWEEIRPDMVILGKALGGGV 
IPVSAVLADKDVMLHIKPGQHGSTFGGNPLASAVAMASLDVIVEEKLVERSASLGEELRI 
QLNEIKKQFPKYIKEVRGRGLFNAIEFNSESLSPVSAYDICLSLKERGVLAKPTHNTIVR 
LTPPLSISSDELRDGSEALHDVLELDLPNLLKINSGKTPVSHITECDRCGRNLYA*
>AT1G55630.1 |  pentatricopeptide (PPR) repeat-containing protein 
MNSVIHYSTSVAVRKASRFLFTSRKFCNGSIGGDVTDNGTEEPLKITWESSEMDCEFDQE 
ENGEKISVRKRFMESTKLSASRVLDTLQQDCPGFNTKSALDELNVSISGLLVREVLVGIL 
RTLSFDNKTRCAKLAYKFFVWCGGQENFRHTANCYHLLMKIFAECGEYKAMCRLIDEMIK 
DGYPTTACTFNLLICTCGEAGLARDVVEQFIKSKTFNYRPYKHSYNAILHSLLGVKQYKL 
IDWVYEQMLEDGFTPDVLTYNIVMFANFRLGKTDRLYRLLDEMVKDGFSPDLYTYNILLH 
HLATGNKPLAALNLLNHMREVGVEPGVIHFTTLIDGLSRAGKLEACKYFMDETVKVGCTP 
DVVCYTVMITGYISGGELEKAEEMFKEMTEKGQLPNVFTYNSMIRGFCMAGKFKEACALL 
KEMESRGCNPNFVVYSTLVNNLKNAGKVLEAHEVVKDMVEKGHYVHLISKLKKYRRS*